Paulus A, Zemaitis M, Cicenas S, Zvirbule Z, et al. Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet. Lung Cancer 2025;206:108664.
PMID: 40680438